EA201650071A1 - Tal-эффекторная нуклеаза для целевого нокаута вич-корецептора ccr5 - Google Patents
Tal-эффекторная нуклеаза для целевого нокаута вич-корецептора ccr5Info
- Publication number
- EA201650071A1 EA201650071A1 EA201650071A EA201650071A EA201650071A1 EA 201650071 A1 EA201650071 A1 EA 201650071A1 EA 201650071 A EA201650071 A EA 201650071A EA 201650071 A EA201650071 A EA 201650071A EA 201650071 A1 EA201650071 A1 EA 201650071A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- tal
- effector
- effector nuclease
- monomer
- target
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/22—Ribonucleases RNAses, DNAses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/111—General methods applicable to biologically active non-coding nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
- C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/80—Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPRs]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Mycology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Изобретение относится к новой TAL-эффекторной нуклеазе (TALEN) для прицельного нокаута ВИЧ-корецептора CCR5. В одном аспекте изобретение представляет пару TAL-эффекторных нуклеаз, включающую в себя первый и второй мономер TAL-эффекторной нуклеазы, причем каждый мономер TAL-эффекторной нуклеазы содержит эндонуклеазный домен со II типом эндонуклеазной активности и ДНК-связывающий домен TAL-эффектора, имеющий множество единиц повтора, каждая из которых имеет вариабельные последовательности из двух аминокислотных остатков (Repeat Variable Diresidue, RVD), и при этом а) ДНК-связывающий домен TAL-эффектора первого мономера TAL-эффекторной нуклеазы связывается с последовательностью-мишенью GCTGGTCATCCTCATCCTG (SEQ ID NO: 1) и/или содержит RVD-последовательность NH HD NG NH NH NG HD NI NG HD HD NG HD NI NG HD HD NG NN, и б) ДНК-связывающий домен TAL-эффектора второго мономера TAL-эффекторной нуклеазы связывается с последовательностью-мишенью AGATGTCAGTCATGCTCTT (SEQ ID NO: 2) и/или содержит RVD-последовательность NI NN NI NG NN NG HD NI NH NG HD NI NG NH HD NG HD NG NG.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102014106327.9A DE102014106327A1 (de) | 2014-05-07 | 2014-05-07 | TAL-Effektornuklease zum gezielten Knockout des HIV-Korezeptors CCR5 |
| PCT/DE2015/200295 WO2015169314A1 (de) | 2014-05-07 | 2015-05-04 | Tal-effektornuklease zum gezielten knockout des hiv-korezeptors ccr5 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EA201650071A1 true EA201650071A1 (ru) | 2017-03-31 |
| EA036375B1 EA036375B1 (ru) | 2020-11-02 |
Family
ID=53761910
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA201650071A EA036375B1 (ru) | 2014-05-07 | 2015-05-04 | Tal-эффекторная нуклеаза для целевого нокаута вич-корецептора ccr5 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20170152496A1 (ru) |
| EP (1) | EP3140398B1 (ru) |
| JP (1) | JP2017514525A (ru) |
| KR (1) | KR102324460B1 (ru) |
| AU (1) | AU2015255366B2 (ru) |
| CA (1) | CA2948198C (ru) |
| CL (1) | CL2016002737A1 (ru) |
| DE (1) | DE102014106327A1 (ru) |
| DK (1) | DK3140398T3 (ru) |
| EA (1) | EA036375B1 (ru) |
| ES (1) | ES2757604T3 (ru) |
| IL (1) | IL248718B (ru) |
| MX (1) | MX2016014556A (ru) |
| SG (1) | SG11201609206QA (ru) |
| WO (1) | WO2015169314A1 (ru) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2018251150B2 (en) | 2017-04-13 | 2024-05-09 | Albert-Ludwigs-Universität Freiburg | New sequence specific reagents targeting CCR5 in primary hematopoietic cells |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2510096B2 (en) | 2009-12-10 | 2018-02-07 | Regents of the University of Minnesota | Tal effector-mediated dna modification |
| CA2798988C (en) * | 2010-05-17 | 2020-03-10 | Sangamo Biosciences, Inc. | Tal-effector (tale) dna-binding polypeptides and uses thereof |
| EP2392208B1 (en) | 2010-06-07 | 2016-05-04 | Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) | Fusion proteins comprising a DNA-binding domain of a Tal effector protein and a non-specific cleavage domain of a restriction nuclease and their use |
| JP2013534417A (ja) | 2010-06-14 | 2013-09-05 | アイオワ ステート ユニバーシティ リサーチ ファウンデーション，インコーポレーティッド | Ｔａｌエフェクターとｆｏｋｉの融合タンパク質のヌクレアーゼ活性 |
| KR101556359B1 (ko) * | 2011-01-03 | 2015-10-01 | 주식회사 툴젠 | 디자인된 tal 이펙터 뉴클레아제를 통한 게놈 엔지니어링 |
| JP6144691B2 (ja) | 2011-11-16 | 2017-06-07 | サンガモ セラピューティクス， インコーポレイテッド | 修飾されたｄｎａ結合タンパク質およびその使用 |
| WO2013182910A2 (en) | 2012-06-05 | 2013-12-12 | Cellectis | New transcription activator-like effector (tale) fusion protein |
| CN103724410B (zh) | 2012-10-12 | 2017-10-03 | 清华大学 | 一类调控ccr5和cxcr4基因的融合蛋白及方法 |
-
2014
- 2014-05-07 DE DE102014106327.9A patent/DE102014106327A1/de not_active Withdrawn
-
2015
- 2015-05-04 US US15/309,406 patent/US20170152496A1/en not_active Abandoned
- 2015-05-04 EP EP15744474.6A patent/EP3140398B1/de active Active
- 2015-05-04 JP JP2017510724A patent/JP2017514525A/ja active Pending
- 2015-05-04 CA CA2948198A patent/CA2948198C/en active Active
- 2015-05-04 ES ES15744474T patent/ES2757604T3/es active Active
- 2015-05-04 KR KR1020167033860A patent/KR102324460B1/ko active IP Right Grant
- 2015-05-04 AU AU2015255366A patent/AU2015255366B2/en active Active
- 2015-05-04 DK DK15744474T patent/DK3140398T3/da active
- 2015-05-04 WO PCT/DE2015/200295 patent/WO2015169314A1/de active Application Filing
- 2015-05-04 SG SG11201609206QA patent/SG11201609206QA/en unknown
- 2015-05-04 MX MX2016014556A patent/MX2016014556A/es active IP Right Grant
- 2015-05-04 EA EA201650071A patent/EA036375B1/ru not_active IP Right Cessation
-
2016
- 2016-10-27 CL CL2016002737A patent/CL2016002737A1/es unknown
- 2016-11-02 IL IL248718A patent/IL248718B/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| AU2015255366B2 (en) | 2021-04-01 |
| CA2948198C (en) | 2023-11-21 |
| DK3140398T3 (da) | 2019-11-25 |
| CA2948198A1 (en) | 2015-11-12 |
| SG11201609206QA (en) | 2016-12-29 |
| ES2757604T3 (es) | 2020-04-29 |
| IL248718B (en) | 2020-05-31 |
| EP3140398A1 (de) | 2017-03-15 |
| WO2015169314A1 (de) | 2015-11-12 |
| KR102324460B1 (ko) | 2021-11-09 |
| JP2017514525A (ja) | 2017-06-08 |
| MX2016014556A (es) | 2017-05-04 |
| CL2016002737A1 (es) | 2017-07-14 |
| KR20170002542A (ko) | 2017-01-06 |
| IL248718A0 (en) | 2017-01-31 |
| US20170152496A1 (en) | 2017-06-01 |
| DE102014106327A1 (de) | 2015-11-12 |
| NZ725905A (en) | 2021-08-27 |
| AU2015255366A1 (en) | 2016-11-24 |
| EP3140398B1 (de) | 2019-08-28 |
| EA036375B1 (ru) | 2020-11-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1124756T1 (el) | Εξουδετερωτικα αντισωματα του ιου ανθρωπινης ανοσοανεπαρκειας | |
| EA201890908A1 (ru) | Композиции и способы для лечения мышечной дистрофии дюшенна и сходных нарушений | |
| MX2021006053A (es) | Composiciones de angiotensinogeno (agt) arni y metodos de uso de las mismas. | |
| EA201792573A1 (ru) | Триспецифические связанные белки и способы их применения | |
| EA201891202A1 (ru) | Композиции, содержащие бактериальные штаммы | |
| EA201891201A1 (ru) | Композиции, содержащие бактериальные штаммы | |
| EA201890050A1 (ru) | Композиции, содержащие бактериальные штаммы | |
| EA201890049A1 (ru) | Композиции, содержащие бактериальные штаммы | |
| EA201890204A1 (ru) | Антибактериальные соединения | |
| EA201591707A1 (ru) | КОМПОЗИЦИИ иРНК КОМПОНЕНТА КОМПЛЕМЕНТА C5 И СПОСОБЫ ИХ ПРИМЕНЕНИЯ | |
| EA201892431A1 (ru) | Олигонуклеотиды для лечения заболевания глаз | |
| EA201990043A1 (ru) | Антибактериальные соединения | |
| EA201890048A1 (ru) | Композиции, содержащие бактериальные штаммы | |
| EA201792673A1 (ru) | 3-арил-4-амидобициклические [4,5,0] гидроксамовые кислоты в качестве ингибиторов hdac | |
| EP3995581A3 (en) | Oligonucleotide compounds for treatment of preeclampsia and other angiogenic disorders | |
| EA201790764A1 (ru) | Новые соединения карбоновых кислот, подходящие для ингибирования микросомальной простагландин-e2-синтазы 1 | |
| EA201891539A1 (ru) | Соединения, ингибирующие металлоферменты | |
| MX2023009652A (es) | Inhibidores peptidicos de la acumulacion de alfa-sinucleina basados en estructuras. | |
| EA202090720A1 (ru) | ПРОИЗВОДНЫЕ GalNAc | |
| BR112017008672A2 (pt) | anticorpos de il-6 melhorados | |
| EA202091731A1 (ru) | Ингибиторы аутотаксина и их применения | |
| EA201792220A1 (ru) | Опосредуемая антителом нейтрализация вируса чикунгунья | |
| EA201791992A1 (ru) | Ингибиторы грелин-o-ацилтрансферазы | |
| BR112017000428A2 (pt) | produtos imunogênicos com base em sequências de amino ácidos muteína b (ab) amiloide e uso dos mesmos | |
| EA201792000A1 (ru) | Ингибиторы грелин-o-ацилтрансферазы |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): KG TJ TM |